Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Chemotherapy and renal toxicity].
Launay-Vacher V, Isnard-Bagnis C, Janus N, Karie S, Deray G. Launay-Vacher V, et al. Bull Cancer. 2008 May 28;95 FMC Onco:F96-103. doi: 10.1684/bdc.2007.0544. Bull Cancer. 2008. PMID: 18511375 French.
Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
Launay-Vacher V, Rey JB, Isnard-Bagnis C, Deray G, Daouphars M; European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Launay-Vacher V, et al. Cancer Chemother Pharmacol. 2008 May;61(6):903-9. doi: 10.1007/s00280-008-0711-0. Epub 2008 Mar 4. Cancer Chemother Pharmacol. 2008. PMID: 18317762 Review.
Lung cancer and renal insufficiency: prevalence and anticancer drug issues.
Launay-Vacher V, Etessami R, Janus N, Spano JP, Ray-Coquard I, Oudard S, Gligorov J, Pourrat X, Beuzeboc P, Deray G, Morere JF; Renal Insufficiency Anticancer Medications (IRMA) Study Group. Launay-Vacher V, et al. Lung. 2009 Jan-Feb;187(1):69-74. doi: 10.1007/s00408-008-9123-5. Epub 2008 Oct 22. Lung. 2009. PMID: 18941834
[Drugs renal toxicity].
Karie S, Launay-Vacher V, Deray G, Isnard-Bagnis C. Karie S, et al. Nephrol Ther. 2010 Feb;6(1):58-74. doi: 10.1016/j.nephro.2009.02.006. Epub 2009 Apr 2. Nephrol Ther. 2010. PMID: 19345176 French.
[Anticancer drugs management in renal insufficiency patients].
Zimmer-Rapuch S, Lheureux S, Brocard F, Janus N, Launay-Vacher V, Ray-Coquard I. Zimmer-Rapuch S, et al. Bull Cancer. 2012 Mar 1;99(3):323-31. doi: 10.1684/bdc.2011.1489. Bull Cancer. 2012. PMID: 22123599 Review. French.
[Management of chemotherapy in hemodialysis patients].
Janus N, Launay-Vacher V, Deray G, Thyss A, Thariat J. Janus N, et al. Bull Cancer. 2012 Mar 1;99(3):371-80. doi: 10.1684/bdc.2011.1483. Bull Cancer. 2012. PMID: 22133734 Review. French.
[Renovascular effects of antiangiogenic drugs].
Deray G, Janus N, Aloy B, Launay-Vacher V. Deray G, et al. Bull Cancer. 2016 Jul-Aug;103(7-8):662-6. doi: 10.1016/j.bulcan.2016.05.005. Epub 2016 Jun 16. Bull Cancer. 2016. PMID: 27318610 Review. French.
[Renal toxicity of anticancer drugs].
Aloy B, Janus N, Isnard-Bagnis C, Deray G, Launay-Vacher V. Aloy B, et al. Among authors: launay vacher v. Nephrol Ther. 2021 Dec;17(7):553-563. doi: 10.1016/j.nephro.2021.09.001. Epub 2021 Nov 18. Nephrol Ther. 2021. PMID: 34802974 French.
177 results